N
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Ireland
Recent Filings
- 8-K236.1 KBNabriva Therapeutics plcFeb 3, 8:45 PM ET·0001104659-23-010788
- 8-K198.7 KBNabriva Therapeutics plcNov 28, 8:01 AM ET·0001104659-22-122226
- 8-K3.9 MBNabriva Therapeutics plcSep 18, 8:00 AM ET·0001104659-17-057510
- 8-K40.5 KBNabriva Therapeutics AGApr 18, 4:39 PM ET·0001104659-17-024183
- 35.9 KBNabriva Therapeutics AGJan 3, 11:49 AM ET·0001225208-17-000028
Insiders
9Tickers
No tickers on record
Addresses
business
25-28 NORTH WALL QUAY
DUBLIN, L2, D01 H104
mailing
414 COMMERCE DRIVE STE 120
FORT WASHINGTON, PA, 19034
Former Names
- Nabriva Therapeutics AG2017-07-10